We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · July 22, 2020

Pituitary Dysfunction Induced by ICIs Is Associated With Better OS in Both Malignant Melanoma and NSCLC

Journal for immunotherapy of cancer


Additional Info

Journal for immunotherapy of cancer
Pituitary Dysfunction Induced by Immune Checkpoint Inhibitors Is Associated With Better Overall Survival in Both Malignant Melanoma and Non-Small Cell Lung Carcinoma: A Prospective Study
J Immunother Cancer 2020 Jul 01;8(2)e000779, T Kobayashi, S Iwama, Y Yasuda, N Okada, T Okuji, M Ito, T Onoue, M Goto, M Sugiyama, T Tsunekawa, H Takagi, D Hagiwara, Y Ito, H Suga, R Banno, K Yokota, T Hase, M Morise, N Hashimoto, M Ando, Y Fujimoto, H Hibi, M Sone, Y Ando, M Akiyama, Y Hasegawa, H Arima

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading